Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe
Response of Plasmodium falciparum to chloroquine treatment was assessed in vivo in 219 malaria cases from eight villages in a formerly hypoendemic area of Zimbabwe experiencing a malaria outbreak. Seven (3%) of the cases were fully sensitive to chloroquine while 182 (83%) exhibited chloroquine-resistant responses. Of the 182 chloroquine-resistant cases 74 (41%) showed RI resistance while 108 (59%) exhibited RII-RIII resistance. In-vivo follow-up was not completed to Day 28 in the remaining 30 (14%) of the malaria cases, which were therefore either fully sensitive or RI resistant. In 23 (11%) of the malaria cases pyrexia and increasing parasitaemia occurred between Day 3 and Day 7 after treatment. Mean parasite clearance time was 5.8 days (s.d. 2.89 days) in patients who were cleared of asexual parasitaemia. In all but 1 (0.5%) of the chloroquine-resistant infections, asexual parasites were cleared by Day 7 following treatment with the sulphadoxine/pyrimethamine combination (Fansidar). This study showed an acute problem of chloroquine resistance in an area of Zimbabwe. It is recommended that the drug policy be modified to allow distribution of limited stocks of Fansidar to the local clinics for restricted use on documented chloroquine treatment failures within 7 days.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1994 |
|---|---|
| Erschienen: |
1994 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:97 |
|---|---|
| Enthalten in: |
The Journal of tropical medicine and hygiene - 97(1994), 1 vom: 18. Feb., Seite 39-45 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mharakurwa, S [VerfasserIn] |
|---|
| Themen: |
37338-39-9 |
|---|
| Anmerkungen: |
Date Completed 24.03.1994 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM019528728 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM019528728 | ||
| 003 | DE-627 | ||
| 005 | 20231222045308.0 | ||
| 007 | tu | ||
| 008 | 231221s1994 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0270.xml |
| 035 | |a (DE-627)NLM019528728 | ||
| 035 | |a (NLM)8107172 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mharakurwa, S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe |
| 264 | 1 | |c 1994 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.1994 | ||
| 500 | |a Date Revised 21.11.2013 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Response of Plasmodium falciparum to chloroquine treatment was assessed in vivo in 219 malaria cases from eight villages in a formerly hypoendemic area of Zimbabwe experiencing a malaria outbreak. Seven (3%) of the cases were fully sensitive to chloroquine while 182 (83%) exhibited chloroquine-resistant responses. Of the 182 chloroquine-resistant cases 74 (41%) showed RI resistance while 108 (59%) exhibited RII-RIII resistance. In-vivo follow-up was not completed to Day 28 in the remaining 30 (14%) of the malaria cases, which were therefore either fully sensitive or RI resistant. In 23 (11%) of the malaria cases pyrexia and increasing parasitaemia occurred between Day 3 and Day 7 after treatment. Mean parasite clearance time was 5.8 days (s.d. 2.89 days) in patients who were cleared of asexual parasitaemia. In all but 1 (0.5%) of the chloroquine-resistant infections, asexual parasites were cleared by Day 7 following treatment with the sulphadoxine/pyrimethamine combination (Fansidar). This study showed an acute problem of chloroquine resistance in an area of Zimbabwe. It is recommended that the drug policy be modified to allow distribution of limited stocks of Fansidar to the local clinics for restricted use on documented chloroquine treatment failures within 7 days | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antimalarials |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a fanasil, pyrimethamine drug combination |2 NLM | |
| 650 | 7 | |a 37338-39-9 |2 NLM | |
| 650 | 7 | |a Sulfadoxine |2 NLM | |
| 650 | 7 | |a 88463U4SM5 |2 NLM | |
| 650 | 7 | |a Chloroquine |2 NLM | |
| 650 | 7 | |a 886U3H6UFF |2 NLM | |
| 650 | 7 | |a Pyrimethamine |2 NLM | |
| 650 | 7 | |a Z3614QOX8W |2 NLM | |
| 700 | 1 | |a Mugochi, T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of tropical medicine and hygiene |d 1945-1946 |g 97(1994), 1 vom: 18. Feb., Seite 39-45 |w (DE-627)NLM000269360 |x 0022-5304 |7 nnns |
| 773 | 1 | 8 | |g volume:97 |g year:1994 |g number:1 |g day:18 |g month:02 |g pages:39-45 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 97 |j 1994 |e 1 |b 18 |c 02 |h 39-45 | ||